Calcium channel antagonists, part I: Fundamental properties: Mechanisms. classification, sites of action Lionel H. Opie OriginalPaper Pages: 411 - 430
Calcium antagonists—Adverse drug interactions H. Reicher-ReissH. N. NeufeldF. X. Ebner OriginalPaper Pages: 403 - 409
Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle Allan M. LeferJohn A. OsborneJian-zhong Sun OriginalPaper Pages: 385 - 391
Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoceptor stimulation in conscious spontaneously hypertensive rats Martin J. M. C. ThoolenCathy R. MillerPieter B. M. W. M. Timmermans OriginalPaper Pages: 377 - 383
Calcium antagonists and acute myocardial ischemia: Comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds Hartmut GülkerWilhelm HaverkampFranz Bender OriginalPaper Pages: 367 - 376
Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: Studies in essential hypertensive man and the spontaneously hypertensive rat Takaaki IsshikiCelso AmodeoEdward D. Frohlich OriginalPaper Pages: 359 - 366
The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade O. VisioliR. BolognesiR. Ferrari OriginalPaper Pages: 353 - 358
Correction of physiological alterations of hypertension Edward D. Frohlich OriginalPaper Pages: 345 - 348
Effects of calcium channel blockers on survival after myocardial infarction Salim YusufCurt D. Furberg OriginalPaper Pages: 343 - 344
What is the solution to sudden cardiac death: Calcium modulation or arrhythmia clinics? William T. Clusin OriginalPaper Pages: 335 - 342
Angiotensin-converting enzyme inhibitors for cardiovascular therapy: Recent advances at the tenth world congress of cardiology Washington DC, September 14–19, 1986 Lionel H. Opie Editorials Pages: 111 - 112
Practical therapy: Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) in therapy of hypertension and congestive heart failure Lionel H Opie Editorials Pages: 109 - 110
Electrophysiological effects mediated by the stimulation of cardiac β2-adrenoceptors with tulobuterol Alessandro MugelliSandra AmeriniSergio Visentin General Articles: Experimental Pharmacology Pages: 101 - 107
Atrial natriuretic factor: Physiologic actions and implications in congestive heart failure Brooks S. EdwardsRobert S. ZimmermanJohn C. Burnett Jr. General Articles: Clinical Studies Pages: 89 - 100
Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris Nardev S. KhurmiEdward B. Raftery General Articles: Clinical Studies Pages: 81 - 87
International nifedipine trial on antiatherosclerotic therapy (intact) Paul Robert LichtlenUlrich NellessenHartmut Hecker Focussed Section: Atherogenesis Pages: 71 - 79
Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits Richard E. SieversTasneem RashidWilliam W. Parmley Focussed Section: Atherogenesis Pages: 65 - 69
Angiotensin-converting enzyme inhibitors: Recent references with editorial comment Lionel H. Opie Focussed Section: ACE Inhibitors Pages: 57 - 64
Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat C. RibuotL. Rochette Focussed Section: ACE Inhibitors Pages: 51 - 55
Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man P. F. SempleA. M. M. CummingJ. J. Morton Focussed Section: ACE Inhibitors Pages: 45 - 50
The role of prostaglandins in mediating the effects of angiotensin converting enzyme inhibitors and other antihypertensive drugs Stephen L. Swartz Focussed Section: ACE Inhibitors Pages: 39 - 43
Angiotensin I converting enzyme inhibitors and the renal excretion of urate William P. LearyAriel J. Reyes Focussed Section: ACE Inhibitors Pages: 29 - 38
Preclinical studies on angiotensin converting enzyme inhibitors Ian Louis Natoff Focussed Section: ACE Inhibitors Pages: 15 - 27
Angiotensin converting enzyme inhibitors in the treatment of hypertension: Efficacy, metabolic effects and side effects Myron H. Weinberger Focussed Section: ACE Inhibitors Pages: 9 - 13
Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure Kanu ChatterjeeLionel H. Opie Focussed Section: ACE Inhibitors Pages: 1 - 8
